Perspective Therapeutics CATX
NYSE CATX
$0.86 +0.02 (+2.38%)
At close: Nov 9, 2026 · 4:00 PM EST

Perspective Therapeutics (CATX) Net Preferred Shares Issued and Repurchased (2013 - 2014)

Updated

Perspective Therapeutics' Net Preferred Shares Issued and Repurchased was $1.48 million in FY2014.

Analysis

Perspective Therapeutics (CATX) Net Preferred Shares Issued and Repurchased (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Perspective Therapeutics 104.44 Mn -132.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -9.00
Dec 31, 2013 -719.00
Sep 30, 2013 1.48 Mn
API Access

Perspective Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CATX&period=max&api_key=YOUR_API_KEY